{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-095596","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2024-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.308706+00:00","generated_at":"2026-05-31T06:45:57.054461+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Standard BioTools Adopts 2024 Change of Control and Severance Plan for Key Executives","bullets":["Plan provides 12 months base salary and full equity vesting for non-COC termination for COO Kim, CLO Gallagher, CCO Davis, and others.","For termination during Change of Control Period: 150% lump-sum of base salary plus bonus, 18-month COBRA, and immediate full equity vesting.","Plan supersedes the 2023 severance plan and covers eight named executives including SVP King, SVP Abou-Sayed, and CHRO Jensen.","Plan term runs until August 4, 2026; CEO Michael Egholm remains covered under separate 2023 plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-095596","json":"https://secwatch.observer/filing/0001104659-24-095596.json","markdown":"https://secwatch.observer/filing/0001104659-24-095596.md","text":"https://secwatch.observer/filing/0001104659-24-095596.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924095596/0001104659-24-095596-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000110465924095596/tm2422827d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:45:57.054461+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}